SRx Health Solutions (SRXH) Cash & Equivalents (2011 - 2025)

SRx Health Solutions has reported Cash & Equivalents for 13 years, with the latest figure at $13.1 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents rose 325.96% year-over-year to $13.1 million; the trailing twelve-month figure through Dec 2025 stood at $13.1 million (up 325.96% YoY), and the FY2025 full-year result was $13.1 million, up 325.96% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $13.1 million, up from $1.3 million in the prior quarter.
• The five-year high for Cash & Equivalents was $26.0 million in Q3 2021, with the low at $106000.0 in Q3 2024.
• Historically, Cash & Equivalents has averaged $6.9 million across 5 years, with a median of $3.8 million in 2023.
• Annual changes were most pronounced in 2021 — Cash & Equivalents jumped 4526.64% — and 2024, when it sank 97.21%.
• SRx Health Solutions' Cash & Equivalents stood at $21.7 million in 2021, then slumped by 56.4% to $9.5 million in 2022, then sank by 52.97% to $4.5 million in 2023, then sank by 31.18% to $3.1 million in 2024, then jumped by 325.96% to $13.1 million in 2025.
• The last three Cash & Equivalents figures came in at $13.1 million (Q4 2025), $1.3 million (Q3 2025), and $912000.0 (Q2 2025), per Business Quant data.